UNITED STATES
SECURITIES AND EXCHANGE COMMISSION September 16, 2014
ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934
Patriot Scientific Corporation
File No. 0-22182 - CF#31373 _____________________
Patriot Scientific Corporation submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 8-K filed on July 30, 2014.
Based on representations by Patriot Scientific Corporation that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit10.10 throughJuly30,2017
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Kevin M. O’Neill Deputy Secretary
